Rappta: Rappta Therapeutics' 9 Million Series A Financing Round
Castrén & Snellman advised Rappta Therapeutics on the deal. Rappta Therapeutics, a Helsinki, Finland-based company focused on developing first-in-class anti-cancer drugs activating protein phosphatase 2A (PP2A), [...]
Read full article »
Rappta is a Finland-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer.
Read more